Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences
International Journal of Neuropsychopharmacology · 2026
DOI: 10.1093/ijnp/pyag022 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2026. Verfasst von Cheng Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China. Hauptthemen laut MEDLINE: Antipsychotic Agents, Adverse Drug Reaction Reporting Systems, Bipolar Disorder, Schizophrenia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Traditional Chinese Medicine Science and Technology Project of Zhejiang Province, Zhejiang Clinovation Pride, Zhejiang Provincial Department of Science and Technology Research Institute Support Program.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
Lumateperone, a novel atypical antipsychotic, has emerged as an illuminating hope for patients with schizophrenia and bipolar disorder. While prior studies have employed spontaneous reporting databases and identified over 100 novel adverse events associated with lumateperone, the differences in these adverse events across subgroups remain unclear.
Objective
This study provides a comprehensive evaluation of the adverse event profile of lumateperone using the Food and Drug Administration Adverse Event Reporting System database, focusing on the potential differences in reporting adverse events across subgroups.
Methods
Based on the results of clinical characteristics and signal detection, the potential differences in reporting lumateperone-associated adverse events across specific subgroups regarding report year, reporter type, sex, age, outcome, indication, and concomitant drug were analyzed using the reporting odds ratio algorithm and Fisher’s exact test with Bonferroni correction. The observed differences were further validated using sensitivity analyses, stratified analyses, and comparative analyses.
Results
This study identified 1762 reports and 5074 adverse events associated with lumateperone. Notably, females had a higher frequency of reporting nervous system disorders. Tardive dyskinesia was more frequently resulted in serious consequences. Moreover, bipolar disorder patients more frequently reported nervous system disorders, while schizophrenia patients more frequently reported psychiatric disorders.
Conclusions
This study underscores the need for future confirmatory studies into the potential sex, outcome and indication differences in adverse events associated with lumateperone. The findings should be considered preliminary and require further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
- Zhejiang Provincial Key Laboratory of Disease-Syndrome Integrated Cancer Prevention and Treatment, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310012, China.
- Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine for Pharmacodynamic Material Basis Research of Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
ORCID-Profile: Cheng Jiang
Förderung
- Traditional Chinese Medicine Science and Technology Project of Zhejiang Province
- Zhejiang Clinovation Pride
- Zhejiang Provincial Department of Science and Technology Research Institute Support Program
- Public Service Technology Research Project of Zhejiang Province
- State Administration of Traditional Chinese Medicine Science and Technology Department-Zhejiang Provincial Administration of Traditional Chinese Medicine Co-co…
Zitieren
APA
Jiang, C., Tang, L., Li, M., & Xia, G. (2026). Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyag022
Vancouver
Jiang C, Tang L, Li M, Xia G. Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences. International Journal of Neuropsychopharmacology. 2026. doi:10.1093/ijnp/pyag022
BibTeX
@article{Jiang2026,
author = {Jiang, Cheng and Tang, Luhan and Li, Mingqian and Xia, Guoqin},
title = {Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences},
journal = {International Journal of Neuropsychopharmacology},
year = {2026},
doi = {10.1093/ijnp/pyag022}
}
EUVIMED